CS logo
small CS logo
Clinvest Research LLC

Springfield, Missouri, United States
Research institute in Springfield, Missouri
909 E Republic Rd Building D 200, Springfield, MO 65807

About Clinvest Research LLC


"Unseeable chronic conditions like migraine, arthritis, and diabetes put a limit on living your best life. We study these conditions so we can bring new treatments to the world. You can help and potentially find help."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
30
Pfizer
18
Cady, Roger, M.D.
12
Allergan
9
Clinvest
4
Dr. Reddy's Laboratories Limited
4
H. Lundbeck A/S
3
Theranica
3
AEON Biopharma, Inc.
2
Amgen
2
Biohaven Pharmaceuticals, Inc.
2
Total Rows: 42

Clinical Trials at Clinvest Research LLC


During the past decade, Clinvest Research LLC conducted 77 clinical trials. In the 10-year time frame, 77 clinical trials started and 49 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 47 clinical trials started and 28 clinical trials were completed. i.e. 59.6% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years884466448813131616181811224410104466131355Started TrialsCompleted Trails2015201620172018201920202021202205101520
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache
2002-01-01
2003-07-01
Completed
60
Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches
2003-12-31
2004-07-31
Completed
189
Evaluation of Histamine, CGRP and VIP as Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers
2004-05-01
2005-11-01
Completed
50
A Study of Rizatriptan Co-Administered With Acetaminophen for the Treatment of Acute Migraine
2006-03-01
2007-01-01
Completed
200
A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia
2006-08-01
2008-12-01
Completed
548
Two Rizatriptan Prescribing Portions for Treatment of Migraine
2006-12-01
2008-01-01
Completed
197
Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia.
2006-12-01
2010-01-01
Completed
560
Efficacy and Safety of TMS for the Preemptive Treatment of Migraine With Aura
2006-08-01
2008-03-01
Completed
201

Rows per page:

1–100 of 127

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Clinvest Research LLC" #1 sponsor was "Eli Lilly and Company" with 30 trials, followed by "Pfizer" with 18 trials sponsored, "Cady, Roger, M.D." with 12 trials sponsored, "Allergan" with 9 trials sponsored and "Clinvest" with 9 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 42 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Clinvest Research LLC" #1 collaborator was "GlaxoSmithKline" with 6 trials as a collaborator, "Allergan" with 3 trials as a collaborator, "Clinvest" with 3 trials as a collaborator, "Clinvest Research, LLC" with 3 trials as a collaborator and "Merck Sharp & Dohme LLC" with 3 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 22 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 30Eli Lilly and Company: 30Pfizer: 18Pfizer: 18Cady, Roger, M.D.: 12Cady, Roger, M.D.: 12Allergan: 9Allergan: 9Clinvest: 4Clinvest: 4Dr. Reddy'sLaboratories Limited: 4Dr. Reddy'sLaboratories Limited: 4H. Lundbeck A/S: 3H. Lundbeck A/S: 3Theranica: 3Theranica: 3AEON Biopharma, Inc.: 2AEON Biopharma, Inc.: 2Amgen: 2Amgen: 2

Created with Highcharts 11.1.0Top CollaboratorsGlaxoSmithKline: 6GlaxoSmithKline: 6Allergan: 3Allergan: 3Clinvest: 3Clinvest: 3Clinvest Research, LLC: 3Clinvest Research, LLC: 3Merck Sharp & Dohme LLC: 3Merck Sharp & Dohme LLC: 3Incyte Corporation: 2Incyte Corporation: 2PPD: 2PPD: 2AlderBiopharmaceuticals,Inc.: 1AlderBiopharmaceuticals,Inc.: 1Avanir Pharmaceuticals: 1Avanir Pharmaceuticals: 1Capnia, Inc.: 1Capnia, Inc.: 1

Clinical Trials Conditions at Clinvest Research LLC


According to Clinical.Site data, the most researched conditions in "Clinvest Research LLC" are "Migraine" (38 trials), "Chronic Migraine" (9 trials), "Type 2 Diabetes" (7 trials), "Migraine Headache" (5 trials) and "Migraine With Aura" (5 trials). Many other conditions were trialed in "Clinvest Research LLC" in a lesser frequency.

Clinical Trials Intervention Types at Clinvest Research LLC


Most popular intervention types in "Clinvest Research LLC" are "Drug" (114 trials), "Device" (9 trials), "Biological" (8 trials), "Other" (6 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (54 trials), "Tirzepatide" (7 trials), "Rimegepant" (5 trials), "Atogepant" (4 trials) and "Dulaglutide" (4 trials). Other intervention names were less common.

Clinical Trials Genders at Clinvest Research LLC


The vast majority of trials in "Clinvest Research LLC" are 126 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Clinvest Research LLC


Currently, there are NaN active trials in "Clinvest Research LLC". undefined are not yet recruiting, 28 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 80 completed trials in Clinvest Research LLC, undefined suspended trials, and 10 terminated clinical trials to date.
Out of the total trials that were conducted in Clinvest Research LLC, 1 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 31 trials, and there were also 6 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 53Phase 3: 53Phase 2: 43Phase 2: 43Phase 4: 31Phase 4: 31Not Applicable: 6Not Applicable: 6Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 80Completed: 80Recruiting: 28Recruiting: 28Terminated: 10Terminated: 10Active, not recruiting: 8Active, not recruiting: 8Enrolling by invitation: 1Enrolling by invitation: 1